安捷伦科技

Agilent Technologies' 15min chart triggered Bollinger Bands Narrowing, KDJ Death Cross Alert.

Agilent Technologies

Agilent Receives Expanded FDA Approval for PD-L1 IHC 22C3 PharmDx in Esophageal or GEJ Carcinoma

Agilent Technologies: MACD Death Cross and KDJ Death Cross Triggered on 15min Chart

Agilent Technologies' 15min chart shows MACD Death Cross, Bollinger Bands narrowing.

Agilent Technologies Acquires Biocare Medical for $950M, Expands Cancer Diagnostics and Clinical Research Capabilities

Catalyst<ul> <li>A recent Bullish Engulfing signal on February 18 indicates potential upward momentum for A.</li></ul>Risk<ul> <li>Bearish signals such as Long Lower Shadow on February 12 and 26 are dominant in recent technical analysis for A.</li> <li>Fund flows show large and extra-large investors are trending negatively, which could pressure A's price.</li></ul>

Key Factors

Agilent Technologies (A) received expanded FDA approval for PD-L1 IHC 22C3 PharmDx as a companion diagnostic for esophageal or GEJ carcinoma patients eligible for Merck's KEYTRUDA treatment.

A News